Controlling Biology - Fabian Theis, Helmholtz Munich
What happened
Fabian Theis, a leading researcher in biological data modeling at Helmholtz Munich, discussed a new $1.8 billion investment into Virtual Cell projects. The funding comes from Biohub, NIH, DOE, Google, and Meta, and is aimed at advancing AI-driven research in biology. This renewed effort is supported by recent progress in imaging and automation technologies, which are now producing large, high-quality datasets. The investment is intended to address previous challenges in modeling complex biological systems by improving data collection and infrastructure.
Key details
- $1.8 billion in new funding committed to Virtual Cell projects
- Funding partners include Biohub, NIH, DOE, Google, and Meta
- Recent advances in imaging technologies such as laser phase plate microscopy and light sheet microscopy
- DOE and NIH are developing large-scale lab automation capabilities
- The Computational Health Center at Helmholtz is integrating AI with molecular and clinical data for predictive modeling
Why it matters
Researchers and companies working in biological modeling and precision medicine will have access to significantly larger and higher-quality datasets, as well as improved infrastructure for AI-driven experiments. This enables more complex and accurate modeling of biological systems, potentially improving the ability to predict and control cellular behavior. The new resources may reduce barriers for labs aiming to use AI in large-scale biological research, changing the scope and scale of experiments they can conduct.